Alzamend Neuro, Inc. (ALZN) — Dilution Risk Analysis
Current Snapshot
Alzamend Neuro, Inc. (ALZN) has a DilutionWatch score of 55/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 55/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 2, 8-K 1, 424B5 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-07-31 | xbrl-6976-xbrl_warrant |
| 8-K | 2026-03-06 | 0001214659-26-002932 |
| 424B5 | 2026-03-06 | 0001214659-26-002941 |
| xbrl | 2022-01-31 | xbrl-6976-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $3,061,933 | Source |
| Cash runway | 11 months | Source |
| Three-year share count growth | 497.37% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 55/10) Source
- Cash Runway
- 11 months Source
- ATM Offering Capacity Remaining
- $3,061,933 Source
- Share Count Growth (3-Year)
- 497.37% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.